Nagarjuna Fertilizers & Chemicals Limited
Nagarjuna Fertilizers & Chemicals Limited
Nagarjuna Fertilizers & Chemicals Limited
The rating revision factors in the successful completion NFCL’s Plant-I operates entirely on natural gas as
of the de-bottlenecking projects, Carbon Di-oxide (CO 2 feedstock and Plant –II uses both natural gas and
) recovery plant and commencement of gas supplies naphtha, in view of the limited gas availability. The plants
from the KG basin by Reliance Industries Limited(RIL). registered over 100% capacity utilizations for the last
The completion of the de-bottlenecking project enhances five financial years, upto FY09.
2 CAREVIEW
(10%), Uhde GmBH (4%) and TIDCO (5%). The project Financial Results
is expected to be come on stream,36 months from the (Rs.cr)
zero date. Y.E. / as on 31 March, 2007 2008 2009
Working Results
NFCL is also planning an additional revamp of its plant
Net Sales( manufactured Urea) 1415 1498 1811
and plans for this are still in the drawing board stage.
Total Income 1463 1460 2120
Financials PBILDT 280 303 329
Interest 138 163 169
Manufactured Urea sales account for largest portion of Depreciation 113 116 120
NFCL’s revenue, increasing by 21% from Rs.1,498 cr PBT 46 40 50
in FY08 to Rs.1,811 cr in FY09. The sharp increase in PAT (after deferred tax) 32 22 33
sales was primarily because of the increase in the Financial position
subsidy payout on account of higher feedstock prices. Total Fixed Assets* 1379 1326 1373
Manufactured Urea sales sans subsidy component Equity Share Capital 428 435 428
increased from Rs.618 cr in FY08 to Rs.648 cr in FY09. Net Worth 891 876 910
This increase in subsidy component was on account of Total Capital Employed 2546 2563 2443
the increased usage of Naphtha (which is priced much Key Ratios(%)
higher than gas), as well as increase in Naphtha and Growth
gas price. Growth in Total optg income (%) 6.74 -0.23 45.20
Growth in PAT [after D.Tax] (%) -52.57 -30.58 47.73
PBILDT has consistently improved in the last three
Profitability
years, from Rs.280 crore in FY07 to Rs.329 cr in FY09.
PBILDT/Total op. Income 19.13 20.75 15.51
Interest cost in FY09 remained at FY08 levels and NFCL
PAT/Total Income (CHK) 2.17 1.51 1.53
reported a higher PAT of Rs.33 cr in FY09 as compared
Solvency
to Rs.22 cr in FY08.
Long Term Debt Equity ratio(times) 1.27 1.26 1.17
NFCL’s exposure to NOCL and JESCO was Rs.763cr Overall Gearing ratio(times) 1.61 1.70 1.49
as on March 31, 2009 which constitutes a significant Interest Coverage(times) 1.19 1.12 1.22
part of the capital employed. Though the company Term Debt/ GCA 9.53 9.30 7.71
expects to realize the balance amount from the sale of Liquidity
equity in JESCO and is confident of the successful Current Ratio(times) 1.14 1.10 1.03
execution of the NOCL project with no additional funding, Quick Ratio(times) 0.98 0.87 0.93
the successful completion of this much delayed project Turnover
remains to be seen. Adjusting for the exposures to these Average Collection Period (days) 63 51 50
subsidiaries would represent substantial erosion to Average Creditors (days) 28 37 45
NFCL’s tangible networth. Average inventory (days)-Manufactured Urea 22 32 16
* Net Fixed Assets+ capital work in progress
NFCL in October, 2007 allotted 2.25 cr warrants to be
converted into equity within 18 months at a price of
Overall gearing has declined in the last few years and
Rs.29 per warrant, to its core promoters. The company
was 1.49x as on March 31, 2009 while interest coverage
had received Rs.6.52 cr being 10% of the value of the
was 1.22x for FY09.
warrants as advance and the balance was to be received
before 25th April, 2009. As the balance amount was not Current ratio was only marginally above unity as on
received, the warrants were annulled and the upfront March 31, 2009. NFCL’s current assets mainly consist
payment stood forfeited. This amount of Rs.6.52 cr was of subsidy / claim receivable from government. Subsidy
represented as part of equity capital as on March 31, receivable as on March 31, 2009 was Rs.307 cr (P.Y-
2008 and this amount has now been added to the capital Rs.256 cr). The under provision of the subsidy in the
reserve. Union Budget and delays in subsidy disbursement or
The Indian Fertiliser industry is highly energy and capital NFCL, in line with the Government policy of utilizing gas
intensive, besides being a highly regulated industry. as a feedstock for the fertilizer units has equipped its
Urea is the main nitrogenous fertiliser produced in the plants to use the additional gas that is being made
country with domestic capacity of around 210 lakh tpa. available from RIL’s KG basin. Gas is a relatively
The last few years have not seen any significant capacity cheaper feedstock as compared to Naphtha and the
addition, while the utilization of capacity has remained availability of gas would ensure higher production levels
high. Demand drivers for fertilisers include the cropping going forward. Continuation of the satisfactory operation
pattern, policy environment, prices, monsoons, use of performance, timely receipt of subsidy from the
high yielding variety of seeds, extent of irrigation etc. Government alongwith NFCL’s ability to exit from
While consumption has been increasing in the last few JESCO and timely implementation of the NOCL project
years, absence of new capacity creation due to the with no additional exposure from NFCL would be key
uncertain policy environment and shortage of gas has rating sensitivities.
led to the country relying on expensive imports.
Note: Dr.N.K.Sengupta, is an Independent Director on the Board
With regard to the policy environment, the industry has of Nagarjuna Agrichem Ltd, an associate company of NFCL and
been for long under the control of the Government. In Independent Director on the Board of CARE. He is also one of the
the case of urea, the government fixes the (farm gate) members of the Rating Committee in CARE. Dr.Sengupta did not
participate in the rating process or in the meeting of the Rating
selling price of urea and the excess of the cost of
Committee when the rating of NFCL was discussed.
production over the selling price, allowing for a suitable
December 2009
Disclaimer
CARE’s ratings are opinions on credit quality and are not recommendations to sanction, renew, disburse or recall the concerned bank
facilities or to buy, sell or hold any security. CARE has based its ratings on information obtained from sources believed by it to be
accurate and reliable. CARE does not, however, guarantee the accuracy, adequacy or completeness of any information and is not
responsible for any errors or omissions or for the results obtained from the use of such information. Most entities whose bank
facilities/instruments are rated by CARE have paid a credit rating fee, based on the amount and type of bank facilities/instruments.
4 CAREVIEW
CARE is headquartered in Mumbai, with Offices all over India. The office addresses and contact numbers are given below:
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway,
Sion (East), Mumbai 400 022 Tel.: (022) 67543456 Fax: (022) 67543457
Website: www.careratings.com
OFFICES